We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FFAI:NASDAQFaraday Future Intelligent Electric Inc. Analysis

Data as of 2026-09-30 - not real-time

$1.30

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Faraday Future Intelligent Electric Inc. trades at $1.30, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 65.1% over the past 30 days. Momentum indicators put RSI at 24.2 (oversold) with MACD reading bullish. Recent trading has carved out support near $1.25 and resistance around $2.24.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 3592.3% above the current quote. Revenue is growing at 1448.1%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 108.9%, a beta of 2.21 and a maximum drawdown of 99.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

FFR has entered into a non-binding term sheet with Faraday Future Intelligent Electric Inc.Buried in a Form 8-K filed with the Securities and Exchange Commission on the morning of September 17, 2026, Faraday...Faraday Future Intelligent Electric Inc. stocks have been trading up by 9.93 percent amid heightened EV sector optimism...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 24.2 signals oversold conditions
  • Trading below the 200-day average of 61.11

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 24.2 signals oversold conditions
  • Trading below the 200-day average of 61.11

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +3592.3% versus the current price
  • Negative return on equity of -1121.0%
  • Revenue growth of +1448.1%

Key Metrics & Analysis

Financial Health

Revenue Growth1448.10%
P/E Ratio-1.1
ROE-1121.00%
ROA-28.55%
Debt/Equity11829.04
P/B Ratio-0.1
Op. Cash Flow$-120495000
Free Cash Flow$-129751376

Technical Analysis

TrendBearish
RSI24.2
Support$1.25
Resistance$2.24
MA 20$1.67
MA 50$3.62
MA 200$61.11
MACDBullish
VolumeIncreasing
Fear & Greed Index92.79

Valuation

Target Price$48.00
Upside/Downside3592.31%
GradeFair
TypeGrowth

Risk Assessment

Beta2.21
Volatility108.92%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.